NCT07628387 Comparative Effects of Aerobic and Muscle Relaxation Exercises in Pregnant Women With Restless Leg Syndrome
| NCT ID | NCT07628387 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Restless Leg Syndrome in Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-10-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be a randomized controlled trial and will be conducted in the Gynecology and Physiotherapy departments of Valencia Health Clinic, Lahore. Non-probability purposive sampling will be used to collect data. A total of 40 pregnant women aged between 20-35 years, in their 2nd or 3rd trimester and clinically diagnosed with RLS, will be included after fulfilling inclusion and exclusion criteria and giving informed consent. Subjects will be randomly divided into two groups using a random number generator table. Group A will receive supervised aerobic exercises for 8 weeks while Group B will undergo progressive muscle relaxation sessions of 20- 25 minutes, also 3 times a week for 8-weeks. Both groups will be assessed at baseline and after the 8-week intervention.
Eligibility Criteria
Inclusion Criteria: * Pregnant women diagnosed with Restless Leg Syndrome based on clinical criteria. * Gestational age between 20 to 34 weeks. * Age range between 20-40 years. * Experiencing moderate to severe sleep disturbance as per Pittsburgh Sleep Quality Index (PSQI score \>5). * Complaints of fatigue and generalized discomfort during pregnancy. Exclusion Criteria: * High-risk pregnancy or obstetric complications (e.g., preeclampsia, placenta previa). * History of neurological or musculoskeletal disorders unrelated to pregnancy. * Any psychiatric disorder or currently taking sedative medications. * History of uncontrolled diabetes mellitus or thyroid dysfunction. * Participation in any structured exercise program or physiotherapy within the last 3 months.
Contact & Investigator
Hafiza Iqra Rubab, MSWHPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07628387 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Restless Leg Syndrome in Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07628387 currently recruiting?
Yes, NCT07628387 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07628387 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07628387 clinical trial?
NCT07628387 is sponsored by Riphah International University. The principal investigator is Hafiza Iqra Rubab, MSWHPT at Riphah International University. The trial plans to enroll 40 participants.